Coefficient Capital Raises $530M Across Two Funds to Double Down on Consumer Brand Disruption
TL;DR
New York-based Coefficient Capital has raised $530 million across two vehicles — a $290M Fund II and a previously unannounced $240M Apex Fund — bringing total AUM to over $800 million. Founded by Franklin Isacson and Andrew Goletka in 2018, the firm backs growth-stage consumer brands in categories undergoing irreversible structural change. With exits including Nom Nom (Mars), Just Spices (Kraft Heinz), Kate Farms (Danone), and the Oatly IPO, Coefficient has built one of the most credible track records in growth-stage consumer venture over the past six years.
Key Takeaways
Consumer venture is not dead — it's bifurcating. The narrative that consumer investing fell out of favor with VCs is partially true: undifferentiated DTC brands with no defensibility have been crushed. But Coefficient's thesis is specifically about categories undergoing irreversible structural change — and their exits prove that when consumer businesses are built with genuine category tailwinds (pet nutrition, clean food, health drinks), large CPG acquirers will pay strategic premiums. This is a different strategy than most consumer VC and deserves to be evaluated separately.
The Apex Fund structure is unusual and worth scrutinizing. Most growth equity firms run sequential numbered funds. Coefficient's decision to run a parallel Apex Fund ($240M) alongside Fund II ($290M) suggests either differentiated LP mandates, differentiated deployment strategies, or separate economics structures. Understanding the differentiation between Fund II and Apex is key for LPs evaluating the combined $530M raise — this is not simply a mega-fund; it may be a more sophisticated capital architecture.
$800M AUM positions Coefficient as a category-defining consumer growth platform. At over $800M in AUM, Coefficient has crossed the threshold from emerging manager to institutional platform. The LP base — hospital systems, university endowments, public pension funds — reflects that institutional confidence, and creates the stickiness that allows long-horizon growth investing without quarterly redemption pressure.
CPG exit market remains structurally active. Mars, Kraft Heinz, Danone, and similar CPG giants remain active acquirers of proven consumer brands at growth stage. This is not a cycle-dependent exit thesis; it is driven by the structural need of large CPG companies to acquire innovation they cannot build internally. Coefficient's portfolio selection — rigorous focus on large categories with secular tailwinds — keeps it on the acquisition radar of the most strategic buyers.
Fund Overview
Fund Name: Coefficient Capital Fund II + Apex Fund
Fund Size: $530M total ($290M Fund II + $240M Apex Fund)
Stage: Growth equity and late-stage
Check Size: Not publicly disclosed
Geography: United States (New York-based)
Focus: Consumer brands in categories undergoing irreversible structural change
Key LPs: Hospital systems, university endowments, global asset management firms, public pension funds, family offices associated with global brands and retailers
Why This Fund Matters
Consumer venture has a reputation problem it doesn't fully deserve. The DTC bubble of 2018-2021 — characterized by companies with high customer acquisition costs, low margins, and no genuine differentiation — justifiably destroyed billions in LP capital. But Coefficient was never playing in that space. Their mandate has always been category disruption at growth stage, not brand creation at seed. The distinction matters enormously: they buy into companies after product-market fit is proven but before CPG acquirers move in, capturing the value creation between growth-stage traction and strategic exit.
The track record bears out this thesis. Mars paid a strategic premium for Nom Nom because the pet nutrition category was undergoing a fundamental shift toward human-grade ingredients, and Nom Nom had built the brand and supply chain to capture it. Kraft Heinz acquired Just Spices for similar reasons — European-origin clean-label seasonings entering the US mass market. These are not lucky exits; they reflect a repeatable pattern of identifying irreversible consumer shifts before large CPG companies are willing to pay for them at auction.
The parallel Apex Fund structure ($240M) deserves more analysis than it has received. Running dual vehicles of similar size but different names suggests Coefficient is serving materially different LP requirements — possibly impact mandates (the hospital system LP base is notable), sector concentration limits, or vintage diversification needs. If the Apex Fund is deployed differently than Fund II, the combined $530M represents a more sophisticated capital deployment strategy than a single large fund.
The LP base is itself a competitive advantage. Hospital systems, university endowments, and global brand-adjacent family offices have non-standard access and intelligence in the consumer market — they see consumption data, demographic trends, and procurement shifts that pure financial LPs miss. In a category where consumer insight is alpha, having these LPs as thought partners is genuinely valuable, not just a fundraising talking point.
The Team
Franklin Isacson and Andrew Goletka co-founded Coefficient Capital in 2018 with a clear mandate: growth equity for consumer categories experiencing irreversible change. Both bring complementary backgrounds in consumer brand finance and venture investing that are relatively rare in a VC industry that disproportionately rewards software expertise. Having invested in 20+ consumer companies over six years across Fund I and Fund II — with exits to Mars, Kraft Heinz, Danone, and a public listing with Oatly — the founding partnership has validated the thesis at scale without the benefit of a DTC tailwind. That is a meaningful durability test.
Early Portfolio
Current Fund II investments include Sincerely Yours (beauty brand) and Untamed (premium pet food). Prior portfolio highlights include Lemme (women's wellness), Gorgie (healthy energy drinks), and Magic Spoon (high-protein breakfast foods). Major exits from the portfolio include Nom Nom (acquired by Mars), Just Spices (acquired by Kraft Heinz), Kate Farms (acquired by Danone), and Oatly (IPO on Nasdaq).
What This Means for Founders
If you are a consumer brand founder who has achieved product-market fit, is growing at 50%+ annually, and operates in a large category with genuine secular tailwinds — clean food, functional wellness, better-for-you snacks, premium pet nutrition — Coefficient Capital is one of the few growth-stage funds that genuinely understands your exit landscape. Their relationships with CPG strategic acquirers are built through portfolio company exits, not just conference networking, which means they can provide real insight into acquisition readiness and pricing dynamics.
Founders should also note the LP base as a distribution resource. Family offices associated with global brands and retailers can be meaningful early customers, retail distribution partners, or co-marketing allies. That LP composition is a deliberate portfolio support mechanism, not an accident of fundraising.
Fund Momentum Take
Coefficient Capital is doing the most intellectually honest version of consumer growth investing: they are not pretending DTC is dead, nor are they chasing brand-of-the-moment hype. The irreversible category disruption thesis is right, the exit track record is strong, and the LP base signals institutional confidence that this is a real category for professional capital, not a boutique niche. $800M+ AUM is the threshold that gives institutional LPs comfortable position sizing.
The parallel fund structure warrants scrutiny. Two vehicles of $290M and $240M deployed simultaneously by a team that has historically operated at smaller scale creates execution risk. How differentiated are the mandates? Are the investment teams for each vehicle the same? GP bandwidth in growth equity — which requires intensive portfolio support — is finite, and $530M is a material step-up from prior fund sizes.
That concern aside: the consumer disruption thesis is one of the most durable in venture, the exits are real, and Coefficient has demonstrated a disciplined approach to category selection that separates them from the DTC bubble era. Fund II and the Apex Fund deserve serious consideration from institutional LPs with consumer exposure mandates.
Frequently Asked Questions
What is Coefficient Capital?
Coefficient Capital is a New York-based growth equity firm founded in 2018 by Franklin Isacson and Andrew Goletka. The firm backs consumer brands in large categories undergoing irreversible structural change, with over $800M in AUM across all funds.
How much did Coefficient Capital raise?
Coefficient raised $530 million across two vehicles: Fund II at $290M and the Apex Fund at $240M, bringing total assets under management to over $800 million.
What are Coefficient Capital's biggest exits?
Key exits include Nom Nom (acquired by Mars), Just Spices (acquired by Kraft Heinz), Kate Farms (acquired by Danone), and Oatly (IPO).
Who are the GPs at Coefficient Capital?
Coefficient Capital was co-founded and is managed by Franklin Isacson and Andrew Goletka.
What stage does Coefficient Capital invest at?
Coefficient focuses on growth equity and late-stage consumer investments — companies that have already achieved product-market fit and are scaling into large category opportunities.
Have a fund closing to announce? Submit your fund here.
Need help raising capital? Check out our Fundraising Advisory services.